Stay updated on Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.

Latest updates to the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior notice for Revision: v3.4.1; these are administrative updates to the site.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice regarding a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a Show glossary feature and updated metadata labels, including Last Update Submitted that Met QC Criteria and No FEAR Act Data, and changed the Revision to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page reflects a minor site revision update from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe study locations section was expanded to include site listings across Alabama, Arkansas, California, Florida, Georgia, Illinois, Kansas, Missouri, Nevada, New Jersey, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, and Wisconsin, with the revision updated to v3.3.3. The HHS Vulnerability Disclosure entry was removed.SummaryDifference2%

- Check92 days agoChange DetectedPublications in the Publications section are now described as automatically filled from PubMed, and the Revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.